Yoshiaki Fujimori has been a director of Boston Scientific since July 2016. He is currently a senior executive advisor of Japan to CVC Capital Partners, a position he has held since February 2017. He was an advisor to the LIXIL Group Corporation from June 2016 to December 2019 and was the president and chief executive officer of the LIXIL Group Corporation from August 2011 to June 2016. Prior to joining LIXIL, he was chairman, president and chief executive officer of GE Japan from January 2008 to June 2011. In his 25 years at GE, beginning in October 1986, he held a variety of positions including senior vice president and chief executive officer of a number of Asian and global business divisions, including Medical Systems, Plastics, and Capital. Mr. Fujimori also served as a member of the GE Corporate Executive Council from 2001 to 2010. Mr. Fujimori is a director of Takeda Pharmaceutical Company Limited, Oracle Corporation, Japan, Shiseido Company, Limited and Toshiba Corporation. Mr. Fujimori received his bachelor’s degree in petroleum engineering from the Tokyo University of Science and his M.B.A from Carnegie Mellon Graduate School of Business, where he serves as a lifetime member of the board of trustees.